Stretch marks — clinically, striae distensae — are so common that calling them a condition almost overstates it: they affect an estimated 60–90% of pregnant people, a large share of adolescents during growth spurts, and many people after rapid weight gain, weightlifting, or prolonged topical or oral corticosteroid use. They appear as linear bands where the dermis has torn under rapid stretching, and they run a predictable course: red and inflamed at first (striae rubra), then fading to pale, atrophic, sometimes depressed lines (striae alba) that can persist for years.
The single most important thing to know before spending money on treatment is that no treatment fully removes mature stretch marks. The realistic goal is improvement — in color, texture, and width — not erasure. The second most important thing is that early, red marks respond much better than mature, white ones, which is why timing matters. This article lays out the evidence ladder for each stage, the skin-of-color considerations that change device choice, and which "treatments" to skip. It is educational and not a substitute for care from a board-certified dermatologist.
Why stretch marks form — and why that determines treatment
Striae distensae are a form of dermal scarring. When skin is stretched faster than it can adapt, the structural proteins (collagen and elastin) in the dermis rupture. The early red or purple color comes from the fine blood vessels and inflammation in the newly torn dermis (striae rubra). Over time the vessels regress, inflammation fades, and the mark becomes pale, thin, and atrophic (striae alba), often with a slightly depressed surface and loss of normal skin texture.
That two-phase course is the key to the whole treatment strategy. Treatments that target blood vessels or inflammation (pulsed-dye laser, certain topicals) work on the early red phase, when the mark is still biologically active. Treatments that rebuild collagen and dermal structure (microneedling, radiofrequency microneedling, fractional lasers) are the backbone for both phases but are especially needed for the mature white phase, where there is no residual inflammation to leverage. Mature striae albae are the hardest to treat — published improvements typically land below 30% — and no device fully restores them.
Prevention: what the evidence actually supports
Prevention is mostly a disappointment. Routine moisturizers and oils do not reliably prevent stretch marks despite their popularity. The better-studied preventive agents in pregnancy are Centella asiatica extract and hyaluronic acid, with some trial data suggesting they may reduce the severity or development of striae gravidarum when used preventively. These effects are modest and not guaranteed. There is no prevention approach with strong, consistent evidence behind it, which is why prevention should not be oversold.
The treatment ladder
Topical retinoids (tretinoin) — for early marks, not for pregnancy
Prescription tretinoin 0.1% has the best topical evidence, specifically for early (rubra) striae. The classic randomized trial of tretinoin versus vehicle showed measurable improvement in early stretch marks, and it works by promoting dermal collagen remodeling and reducing the inflammatory component. The hard limit: tretinoin is a retinoid and is contraindicated in pregnancy and breastfeeding. For a pregnant patient whose marks are actively forming, tretinoin is not an option — and most marks of greatest cosmetic concern appear during pregnancy. Over-the-counter retinol is far weaker and has minimal evidence in striae.
Microneedling — the workhorse, and the safest for skin of color
Microneedling creates controlled micro-injuries that trigger a wound-healing response and new collagen, which is exactly what an atrophic stretch mark needs. The evidence is consistent and encouraging: in studied series, patients achieved at least 50% improvement, with some reaching over 75% after only one to two sessions, and the procedure is well tolerated across skin types I–V with minimal downtime. In broader clinical practice a full course runs three to six sessions spaced four to six weeks apart, with newer red marks often responding in two to three and mature white marks typically needing the full series. Crucially for Fitzpatrick IV–VI patients, microneedling's post-inflammatory hyperpigmentation (PIH) risk is low compared with heat-based devices, because it does not deposit thermal energy that stimulates melanin. For stretch marks on the trunk and extremities — where skin is thicker and devices are often used off-label — microneedling is one of the most cost-effective and color-safe options.
Radiofrequency (RF) microneedling — more remodeling, more discomfort
Adding radiofrequency energy to the needles delivers heat deeper into the dermis, intensifying collagen and elastin remodeling. A meta-analysis pooling 11 studies found that microneedle radiofrequency produced more significant clinical improvement than laser treatment for striae — but with significantly more post-procedure pain. RF microneedling (devices such as Morpheus8, Sylfirm X, Potenza, Secret RF) is a strong choice for texture and depth, especially in combination protocols. The tradeoff versus plain microneedling is comfort and, in darker skin, a modestly higher (though still manageable) pigment risk from the thermal component.
Fractional lasers — effective, especially for white marks, with a pigment caveat
Fractional resurfacing lasers — both ablative fractional CO2 and non-ablative fractional (1540/1550 nm Er:Glass) — remodel collagen through controlled thermal injury and have real evidence in striae.
- Ablative fractional CO2 is particularly used for mature, white striae (alba), where it can improve texture and width. Its main drawback is a higher PIH and recovery burden, which makes it a riskier choice in darker skin.
- Non-ablative fractional lasers (1540/1550 nm) are better tolerated in darker skin types and show significant reductions in erythema and improvements in skin elasticity, making them a reasonable balance of efficacy and pigment safety for Fitzpatrick IV–VI.
The choice between ablative and non-ablative often comes down to skin type and downtime tolerance, not just stretch-mark severity.
Pulsed-dye laser (585 nm) — for the red phase only
The pulsed-dye laser targets hemoglobin in blood vessels, which makes it effective against the vascular component of early, red striae (rubra). It can reduce redness relatively quickly. It has little to offer mature white marks, where there are no vessels left to target. PDL is often combined with other modalities in a staged plan.
Combination therapy — where the strongest results sit
Across recent reviews and meta-analyses, the clearest signal is that combination therapy outperforms any single modality, especially for resistant mature marks. Common, evidence-backed pairings include RF microneedling combined with fractional CO2 laser, and either modality combined with platelet-rich plasma (PRP). One network meta-analysis found bipolar radiofrequency combined with topical tretinoin produced the best clinical effectiveness (about 84.5%) and patient satisfaction (about 95.7%). The practical pattern: use microneedling or RF microneedling to rebuild dermis, layer a laser or PRP for synergy, and reserve tretinoin for patients who are not pregnant.
Chemical peels — a supporting option
Medium-depth trichloroacetic acid (TCA) peels in the 15–20% range, repeated at monthly intervals, have shown improvement in skin texture, firmness, and color around stretch marks, particularly newer ones. Peels are a supporting rather than primary tool, and PIH risk in darker skin means concentration and technique must be chosen carefully.
A practical table by stage and skin type
| Situation | Reasonable first-line options | Avoid / caution |
|---|---|---|
| Early red marks (rubra), light skin | Pulsed-dye laser; tretinoin 0.1% (if not pregnant) | Overpriced "stretch-mark creams" |
| Early red marks, darker skin (IV–VI) | Non-ablative fractional 1540/1550 nm; microneedling | Ablative CO2 (PIH risk); IPL |
| Mature white marks (alba) | RF microneedling + fractional CO2; PRP combination | Expecting full removal |
| During pregnancy / breastfeeding | Centella asiatica / hyaluronic acid prevention; defer device treatment | Tretinoin and retinoids (teratogenic) |
| Sensitive to cost | Microneedling (best value, color-safe) | Bundled multi-device packages before a clear plan |
What no device can do
Setting expectations matters here because the marketing for stretch-mark treatment is aggressive. No device, peel, or cream restores a mature white stria to normal skin. Realistic outcomes are partial improvement in width, color, and texture — visible on close inspection but not "erasure." Across published series and clinic experience, patients can expect roughly a 40–80% reduction in visibility depending on mark age, depth, and type, with newer red marks at the high end and mature white marks at the low end. Patients who expect their abdomen to look as it did before pregnancy, or their growth-spurt marks to disappear, will be disappointed by any honest provider. The patients most satisfied are usually those treating active red marks early, or those who treat mature marks across a multi-session combination plan with a clear understanding that improvement, not removal, is the endpoint.
What it costs
Stretch-mark treatment is cosmetic and is not covered by insurance. Per-session pricing in 2025 generally falls in the $150–$500 range, varying with modality, practice, and geography — with energy-based treatments (fractional laser, RF microneedling) at the higher end and standard microneedling toward the lower end. Because a realistic course is three to six sessions, the total for a single body area commonly lands in the low thousands, and combination protocols cost more. The value calculation favors microneedling for patients who are cost-sensitive or in darker skin types, since it carries the lowest per-session cost and the lowest pigment risk while delivering the most consistent mid-range improvement. As with any cash-pay aesthetic course, the all-in price for the planned number of sessions — not the headline per-session figure — is the number to compare.
Skin-of-color considerations
In Fitzpatrick IV–VI skin, the dominant risk across all energy-based stretch-mark treatments is post-inflammatory hyperpigmentation — the treatment itself can leave dark marks that outlast the original stretch mark. This is why the ladder shifts for darker skin: plain microneedling and non-ablative fractional lasers move up, while ablative CO2 and IPL move down or require an experienced provider. Any device plan in skin of color should be built around pigment safety first, efficacy second. Topical tyrosinase inhibitors and rigorous sun protection may be used alongside device treatment to manage PIH risk.
What to ask a provider
- Are my marks still red (rubra) or mature white (alba)? The answer should change the proposed plan.
- Given my skin type, which device carries the lowest PIH risk? A credible answer names microneedling or non-ablative fractional for darker skin.
- How many sessions, at what interval, and what total cost — and what realistic improvement should I expect?
- Is tretinoin appropriate for me, and am I clear that it is not safe in pregnancy or breastfeeding?
- Is this a single-modality plan or a combination, and why? The evidence favors combination for mature marks.
Stretch marks are normal, common, and biologically well understood. Treatment can improve them meaningfully — most reliably when they are still red, and most safely in darker skin when pigment risk is built into the plan from the start. What treatment cannot do is erase them, and a provider who promises otherwise is not the one to perform it.
Sources
- PMC — Advances in the Treatment of Striae Distensae (microneedle RF vs laser, fractional devices, PDL, combination therapy): https://pmc.ncbi.nlm.nih.gov/articles/PMC12820439
- PMC — Advancements in treating stretch marks across all skin types (microneedling in skin of color, combination protocols, treatment algorithm): https://pmc.ncbi.nlm.nih.gov/articles/PMC12799299
- Frontiers in Medicine — 1550 nm Er:Glass vs CO2 fractional laser for striae albae (self-controlled study): https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2022.1060815/full
- EMJ Dermatology — Treating Stretch Marks with Combination Care (review of combination vs monotherapy outcomes): https://www.emjreviews.com/dermatology/news/treating-stretch-marks-with-combination-care
- Medscape / eMedicine — Striae Distensae Treatment & Management (peels, lasers, RF, tretinoin evidence): https://emedicine.medscape.com/article/1074868-treatment
- Peer-reviewed review — Striae distensae treatment modalities literature review (topicals, microneedling, fractional CO2 outcomes): https://rspublisher.org/index.php/ijitss/article/view/3760
